Children's Hospital of Philadelphia and St. Jude Researchers Find Genetic Ancestry Influences How Gene Mutations Impact Cancer Prognosis in Patients With T-cell Acute Lymphoblastic Leukemia
Study is the first to explore the impact of genetic ancestry on tumor genomics in T-ALL
PHILADELPHIA and MEMPHIS, Tenn., June 24, 2025 /PRNewswire/ -- Investigators at Children's Hospital of Philadelphia (CHOP), St. Jude Children's Research Hospital (St. Jude), Dana Farber Cancer Institute (DFCI), and the Children's Oncology Group (COG), unveiled for the first time that changes in certain genes affect an aggressive cancer, T-cell acute lymphoblastic leukemia (T-ALL), differently depending on genetic ancestry. The collaborative study, published recently in the journal Blood Cancer Discovery, further reinforces the critical role of personalized medicine in advancing the treatment of pediatric cancers such as T-ALL.
Most children in the U.S. newly diagnosed with cancer are treated through clinical trials or with regimens established by earlier trial findings. Increasingly, these frontline trials use prognostic biomarkers to guide treatments related to whether patients have high risk or low risk disease. While previous studies found that genetic ancestry affects how certain gene changes appear in cancer, researchers can now show that these gene changes may also predict outcomes differently depending upon an individual's ancestry.
'Our research demonstrates it is essential to ensure the equitable implementation of genomic biomarkers in treatment decisions or we may introduce disparities,' said David T. Teachey, MD, a lead study author at CHOP and Chair of the Acute Lymphoblastic Leukemia Disease Committee in the COG. 'Without this critical step, we risk misclassifying patients into the incorrect high- or low-risk groups, potentially causing undertreatment and increased risk of relapse, or overtreatment and unnecessary side effects, especially in populations of non-European descent.'
Study participants were enrolled in the COG's multicenter phase 3 randomized clinical trial AALL0434 (NCT04408005) conducted from 2007 to 2014. Of the eligible participants evaluable with T-ALL, researchers analyzed complete sequencing for 1,309 individuals included in this study. They found that 80% had mutations in genes where prognostic impact varied depending on their genetic ancestry. For example, a gene called NOTCH1 was linked to better survival in patients of European ancestry but was not associated with better survival in patients of African ancestry. Importantly, this collaborative study brought together experts in the diagnosis and treatment of T-ALL, leukemia genomics, genetic ancestry and social determinants of health research, including study co-author Kira Bona, MD, MPH from DFCI.
'The study provides another important example of the way in which heritable and tumor-acquired genetic variations interact to determine the features and behavior of leukemia,' said study author Charles Mullighan, MBBS (Hons), MSc, MD, Senior Deputy Director of the St. Jude Comprehensive Cancer Center.
The study evaluated tools that group patients into risk categories. One method worked well for everyone, no matter their ancestry. But another tool used, developed mainly from European data, sometimes gave misleading results for people from backgrounds other than European ancestry. The researchers also emphasized that certain genetic ancestries may be associated with more aggressive disease forms or different responses to treatment.
'Our groups have a long-standing interest in how genetic ancestry affects cancer biology in children. This study is another example of the fruitful collaboration with COG that led to the discovery of new genetic basis of racial/ethnic differences in leukemia,' said co-corresponding author Jun J. Yang, PhD, Endowed Chair in Pharmacogenomics of the St. Jude Department of Pharmacy and Pharmaceutical Sciences.
'The lessons learned from this work should be investigated in other types of cancer in children and adults to improve outcomes for patients of all ancestral backgrounds,' said first author Haley M. Newman, MD, a junior faculty member at CHOP.
The research was supported by K12CA076931-24, Gabriella Miller Kids First (X01HD100702), R03CA256550, Alex's Lemonade Stand Foundation, the Leukemia and Lymphoma Society, Singapore NMRC, Singapore NUHS NCSP, Hyundai Hope on Wheels, (R01CA193776),(U10CA180886), (R01CA264837), (U24CA114766), (U24CA196173), (U10CA180899, St.Baldricks Research Foundation, Pennsylvania Department of Health, the Harrison Willing Memorial Research Fund, The Invisible Prince Foundation, the Aiden Everett Davies Innovation Fund, ALSAC the fundraising and awareness organization of St. Jude, The St. Jude Chromatin Collaborative, (P30CA021765), (R35CA197695), (U54CA243124) and the Canadian Institute for Health Research.
Newman et al. 'Impact of Genetic Ancestry on Genomics and Survival Outcomes in T-cell Acute Lymphoblastic Leukemia.' Blood Cancer Discov. Online May 28, 2025. DOI: 10.1158/2643-3230.BCD-25-0049.
About Children's Hospital of Philadelphia:
A non-profit, charitable organization, Children's Hospital of Philadelphia was founded in 1855 as the nation's first pediatric hospital. Through its long-standing commitment to providing exceptional patient care, training new generations of pediatric healthcare professionals, and pioneering major research initiatives, the hospital has fostered many discoveries that have benefited children worldwide. Its pediatric research program is among the largest in the country. The institution has a well-established history of providing advanced pediatric care close to home through its CHOP Care Network, which includes more than 50 primary care practices, specialty care and surgical centers, urgent care centers, and community hospital alliances throughout Pennsylvania and New Jersey. CHOP also operates the Middleman Family Pavilion and its dedicated pediatric emergency department in King of Prussia, the Behavioral Health and Crisis Center (including a 24/7 Crisis Response Center) and the Center for Advanced Behavioral Healthcare, a mental health outpatient facility. Its unique family-centered care and public service programs have brought Children's Hospital of Philadelphia recognition as a leading advocate for children and adolescents. For more information, visit https://www.chop.edu.
About St. Jude Children's Research Hospital
St. Jude Children's Research Hospital is leading the way the world understands, treats and cures childhood cancer, sickle cell disease and other life-threatening disorders. It is the only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children. Treatments developed at St. Jude have helped push the overall childhood cancer survival rate from 20% to 80% since the hospital opened more than 60 years ago. St. Jude shares the breakthroughs it makes to help doctors and researchers at local hospitals and cancer centers around the world improve the quality of treatment and care for even more children. To learn more, visit stjude.org, read St. Jude Progress a digital magazine, and follow St. Jude on social media at @stjuderesearch.
Contact: Jennifer Lee
Children's Hospital of Philadelphia
(267) 426-6084
[email protected]
Contact: Michael Sheffield
St. Jude Children's Research Hospital
(901) 379-6072
[email protected]
[email protected]
View original content: https://www.prnewswire.com/news-releases/childrens-hospital-of-philadelphia-and-st-jude-researchers-find-genetic-ancestry-influences-how-gene-mutations-impact-cancer-prognosis-in-patients-with-t-cell-acute-lymphoblastic-leukemia-302488717.html
SOURCE Children's Hospital of Philadelphia
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
5 hours ago
France to ban smoking in parks, beaches, and near schools
PARIS -- France has struggled to kick its smoking habit. A new public health decree published Saturday aims to change that. In the coming days, smoking will be banned in all French parks and sports venues, at beaches and bus stops, in a perimeter around all schools, and anywhere children could gather in public. In a country where smoking has for generations been glamorized in cinema and intertwined with the national image, government crackdowns on tobacco use have met resistance. 'In France, we still have this mindset of saying, 'this is a law that restricts freedom,''' Philippe Bergerot, president of the French League Against Cancer, told the Associated Press. The ban aims ''to promote what we call denormalization. In people's minds, smoking is normal,'' he said. ''We aren't banning smoking; we are banning smoking in certain places where it could potentially affect people's health and ... young people.'' It's been illegal to smoke in restaurants, bars and public buildings since a series of bans in 2007 and 2008. Ever-higher taxes mean a pack now costs upwards of 12 euros ($14). Yet more than 30% of French adults still smoke cigarettes, most of them daily, one of the higher rates in Europe and globally. The Health Ministry is particularly concerned that tobacco remains popular among young people, citing public health statistics showing that 15% of 17-year-olds smoke. Black market cigarette trading is common. More than 200 people in France die each day of tobacco-related illness, Health Minister Catherine Vautrin said in a statement Saturday. That adds up to some 75,000 deaths per year. In a Paris park as the ban loomed, views were mixed. Parisian Natacha Uzan welcomed the end of smoking in restaurants. But she said: ''Now outside, in parks, I find it becoming a bit repressive.' The broader ban is a ''good thing'' for Anabelle Cermell, mother of a 3-month-old boy. ''I tell myself, oh, it's really not ideal for him, but there's not much I can do about it, or I would have to ... not take the bus, not go to parks.' The government said last month that the new ban would take effect July 1. The official decree introducing the ban was published Saturday, and a health minister's statement said that a government order specifying the perimeters set by the ban would be published in the coming days. Electronic cigarettes are exempt from the new ban. Other European countries have gone farther. Britain and Sweden have tightened smoking regulations in public spaces. Spain is extending its smoking ban to café and restaurant terraces, which are exempt from France's new ban.
Business Upturn
10 hours ago
- Business Upturn
Rainbow Children's Medicare acquires majority stake in Prashanthi Hospital
By Aman Shukla Published on June 28, 2025, 14:30 IST Rainbow Children's Medicare Limited (RCML) has announced the acquisition of a majority stake in Prashanthi Medicare Private Limited, a reputed 100-bed NABH-accredited hospital in Warangal, Telangana. The acquisition marks a strategic expansion into tier-II cities and enhances RCML's presence in southern India. Established in 2015 by Dr. Prasanthi Macha, Prashanthi Hospital is recognized for excellence in obstetrics, gynecology, neonatology, pediatrics, and minimally invasive surgery. The hospital has built a strong regional reputation and continues to serve as a trusted destination for maternal and child healthcare in Warangal, Telangana's second-largest district. With this acquisition, RCML's total bed capacity increases to 2,035 across 20 hospitals in seven cities. The transaction, valued at approximately ₹32.60 crore (subject to working capital adjustments), is based on 9x estimated FY25 adjusted EBITDA and will be funded through internal accruals and cash reserves. RCML will acquire a 76% equity stake and 100% of the Non-convertible Redeemable Preference Shares (NCRPS), while Dr. Macha and associates will retain a 24% minority stake. Post-acquisition, the facility will operate under a dual brand: Rainbow Children's Hospital for pediatric services and Prashanthi with BirthRight for women's health services. The integration will support RCML's hub-and-spoke model, ensuring efficient referrals and clinical alignment with its Hyderabad tertiary care hub. Ahmedabad Plane Crash Rainbow Children's Medicare Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
Indianapolis Star
a day ago
- Indianapolis Star
RFK Jr. says there may be 'more cavities' under fluoride bans: 'It's a balance'
Health and Human Services Secretary Robert F. Kennedy Jr. said on Thursday that nixing fluoride from public drinking water may result in more cavities. "It's a balance," Kennedy said during interview on Fox News' "The Faulkner Focus" on Thursday, June 26. "You're going to see probably slightly more cavities. Although in Europe, where they ban fluoride, they did not see an uptick in cavities. The issue is parents need to decide because the science is very clear on fluoride." Fluoridation is not banned in Europe, according to the American Dental Association (ADA). However, adding fluoride to drinking water is not as widespread in European countries as in the U.S. Some European countries fluoridate their water, while others do not and the reasoning and result of those actions varies, according to BBC reporting. USA TODAY has reached out to ADA for more information. Kennedy's response came after anchor Harris Faulkner asked him how removing fluoride from public drinking water would affect children who don't have access to dentists or proper oral healthcare. Kennedy has been pushing to ban fluoride in public drinking water. In April, during a meeting with President Donald Trump, he said that kids get "stupider" the more fluoride they take in. Kennedy's remarks were met with backlash, as the study he pulled from was criticized for inadequate statistical rigor and other methodological flaws. A Department of Health and Human Services spokesperson told USA TODAY on June 27 that Kennedy's comments reflect an effort to balance reducing exposure to unnecessary chemicals while maintaining protections, like preventing cavities in children. The Department of Health and Human Services has advised the Centers for Disease Control and Prevention (CDC) to meet with the Community Preventative Services Task Force to study and make a new recommendation on fluoride, the spokesperson added. Fluoride bans: Two states have now passed fluoride bans. These other ones introduced bills. Fluoride is a naturally-occurring mineral found in many foods and water and has been long thought to help prevent tooth decay, according to the Cleveland Clinic. Throughout the day, the protective outer layer of our teeth, called enamel, breaks down. Natural minerals within the enamel are broken down by bacteria, plaque and sugar. This is called demineralization. To gain these minerals back, people must consume food and water that contains chemicals like fluoride, calcium and phosphate, the Cleveland Clinic states. This is known as remineralization. The Cleveland Clinic says with too much demineralization and not enough remineralization, tooth decay may begin. Exclusive: As RFK Jr. targets fluoride, Texas is coming for kids toothpaste In 1945, Grand Rapids, Michigan, became the first city to fluoridate its community water, adjusting existing levels in the supply to the therapeutic 1.0 parts-per-million (ppm). Since then, the levels have been adjusted to a maximum of 0.7 ppm or 0.7 milligrams of fluoride per liter of water, which is considered optimal for preventing tooth decay. Health risks from exposure to fluoride require a much higher concentration, according to the American Dental Association. To get fluoride toxicity from drinking treated water, a person would have to consume 5 liters of water per kilogram of body weight, meaning the average person would die from drinking too much water before fluoridation of that water could hurt them, according to the Cleveland Clinic. Utah and Florida have banned fluoride from public drinking water – Utah in March and Florida in May. Kennedy has championed these states, and others looking to pass bans, including Kentucky, Louisiana, Massachusetts, Nebraska, South Carolina, North Dakota, Arkansas, Tennessee, Montana and New Hampshire. After Utah passed its fluoride ban in March, the ADA released a statement saying dentists "see the direct consequences fluoride removal has on our patients." "It's a real tragedy when policymakers' decisions hurt vulnerable kids and adults in the long term. Blindly calling for a ban on fluoridated water hurts people, costs money and will ultimately harm our economy," ADA President Dr. Brett Kessler said in a news release. The ADA has also pointed to studies, like one 2024 study conducted by the University of Queensland, which found that children exposed and not exposed to fluoride showed no difference in IQ testing. This story was updated to add more information. Contributing: Natalie Neysa Alund, Swapna Venugopal Ramaswamy and Mary Walrath-Holdridge, USA TODAY
